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ERADICATION OF METHICILLIN-RESISTANT 
STAPHYLOCOCCUS AUREUS FROM A NEONATAL 
INTENSIVE CARE UNIT BY ACTIVE SURVEILLANCE 
AND AGGRESSIVE INFECTION CONTROL MEASURES
Jad Khoury, MD; Marilyn Jones, RN, CIC; Autumn Grim, MPH; Wm. Michael Dunne, Jr., PhD; Vicky Fraser, MD
OBJECTIVES: To describe an outbreak of hospital- 
acquired MRSA in a NICU and to identify the risk factors for, 
outcomes of, and interventions that eliminated it.
SETTING: An 18-bed, level III–IV NICU in a community 
hospital.
METHODS: Interventions to control MRSA included active 
surveillance, aggressive contact isolation, and cohorting and de-
colonization of infants and HCWs with MRSA. A case–control study 
was performed to compare infants with and without MRSA.
RESULTS: A cluster of 6 cases of MRSA infection be-
tween September and October 2001 represented an increased 
attack rate of 21.2% compared with 5.3% in the previous months. 
Active surveillance identified unsuspected MRSA colonization 
in 6 (21.4%) of 28 patients and 6 (5.5%) of 110 HCWs screened. 
They were all successfully decolonized. There was an increased 
risk of MRSA colonization and infection among infants with low 
birth weight or younger gestational age. Multiple gestation 
was associated with an increased risk of colonization (OR, 37.5; 
CI95, 3.9–363.1) and infection (OR, 5.36; CI95, 1.37–20.96). Ga-
vage feeding (OR, 10.33; CI95, 1.28–83.37) and intubation (OR, 
5.97; CI95, 1.22–29.31) were associated with increased risk of 
infection. Infants with MRSA infection had a significantly longer 
hospital stay than infants without MRSA (51.83 vs 21.46 days; 
P = .003). Rep-PCR with mec typing and PVL analysis confirmed 
the presence of a single common strain of hospital-acquired 
MRSA.
CONCLUSION: Active surveillance, aggressive imple-
mentation of contact isolation, cohorting, and decolonization ef-
fectively eradicated MRSA from the NICU for 2½ years following 
the outbreak (Infect Control Hosp Epidemiol 2005;26:616-621).
ABSTRACT
Several outbreaks of methicillin-resistant Staphylo-
coccus aureus (MRSA) infections in neonatal intensive care 
units (NICUs) have been described since the early 1980s. 
Efforts to eradicate and control MRSA colonization and 
infection have had variable degrees of success and recur-
rences of MRSA outbreaks have been described.1 Haley et 
al. illustrated the difﬁculties encountered with controlling 
a MRSA outbreak in their NICU that lasted more than 3 
years.2 On the other hand, Farrington et al. reported the 
success of simple control measures to restrict the spread of 
MRSA in a special care baby unit.3 Implementation of MRSA 
control efforts in NICUs has been hindered by additional 
factors such as overcrowding and limited space.4 Despite 
variable outcomes of MRSA control measures, early recog-
nition of outbreaks and institution of aggressive infection 
control measures have been shown to be cost-effective.5,6
We describe the successful eradication of a hospital-ac-
quired strain of MRSA from a NICU and the infection control 
methods used to halt an outbreak that had been going on for 
months, as well as the risk factors for and outcomes of in-
fection or colonization with MRSA. This study describes the 
effects of active surveillance and aggressive infection control 
measures in successfully terminating a MRSA outbreak in 
the NICU of a community hospital. 
METHODS
Setting
The medical center is a community hospital with 300 beds, 
and the NICU is a level III–IV unit with 18 beds that has an aver-
age of 170 admissions per year and an estimated census of 10 to 12 
patients daily. The NICU is divided into two large rooms designated 
room 1 and room 2. These rooms are further divided into a total of 
5 sections, each with 2 to 5 beds used for routine admissions; room 
1 has an additional section with 3 isolation beds. 
Outbreak
A cluster of six cases of MRSA infection were identi-
ﬁed in the NICU from early September 2001 to mid-Octo-
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ber 2001, representing an increase in the incidence of 
MRSA compared with the previous year. A review of the 
infection control policies and procedures for the NICU 
was performed, and changes and remedies were intro-
duced where necessary to control the spread of MRSA 
and prevent future outbreaks. Infection control nurses 
ensured the proper application of infection control mea-
sures.
Cultures and Microbiology
Routine surveillance of all clinical cultures positive 
for MRSA throughout the hospital had been used by infec-
tion control to monitor the incidence of nosocomial MRSA 
infections. This routine surveillance identiﬁed the cluster 
of 6 cases in the NICU and prompted the institution of ac-
tive culture surveillance on October 14, 2001. Samples for 
screening cultures for MRSA were obtained by swabbing 
the periumbilical and perirectal areas of all of the infants 
present in the NICU on October 14, 2001, and all newly 
admitted patients until the end of January 2002. These 
surveillance cultures for MRSA were repeated weekly. A 
total of 28 infants were screened. In addition, samples for 
screening cultures were obtained once from the anterior 
nares of 110 healthcare workers (HCWs) working in the 
NICU. Those who were colonized with MRSA underwent 
3 repeat nasal cultures on a weekly basis after receiving 
decolonization treatment to document clearance and iden-
tify persistent carriage.
The identification of MRSA from screening cul-
tures was performed using oxacillin salt agar plates ac-
cording to the methods recommended by the National 
Committee for Clinical Laboratory Standards.7 All 
MRSA isolates obtained from NICU patients and HCWs 
from September 1, 2001, through January 2002 were 
saved for molecular typing and analysis of the SCCmec 
cassette and Panton–Valentine leukocidin. 
Infection Control Measures
A unit-wide cleaning with routinely used quaternary 
ammonium disinfectants took place at the beginning of 
the outbreak in October 2001, but no environmental cul-
tures were performed. NICU infants who were infected or 
colonized with MRSA were placed in contact isolation and 
cohorted geographically. Infection control nurses directly 
observed HCWs and educated them about proper contact 
isolation techniques and the importance of meticulous 
hand hygiene, emphasizing handwashing with soap or alco-
hol-based foam before and after every patient contact. Vis-
ible signs were placed on the beds of infected or colonized 
patients to remind the NICU staff and patients’ families 
about the need for contact isolation and hand hygiene. Con-
tact isolation required the use of barrier precautions such 
as gloves, gowns, and sometimes masks for all direct pa-
tient contact.  
Decolonization
Colonized patients received mupirocin ointment 
twice daily to the anterior nares and umbilical area for 7 
days. HCWs who had a nasal culture positive for MRSA 
took a hexachlorophene shower daily and received the fol-
lowing twice daily for 1 week: 600 mg of rifampin orally, one 
double-strength tablet of trimethoprim–sulfamethoxazole 
orally, and mupirocin ointment to the anterior nares.
Molecular Typing
Repetitive sequence polymerase chain reaction 
(PCR) genotyping was used to study the clonality of the 
MRSA isolates. DNA isolation and ampliﬁcation with 
RW3A primer were performed as previously described by 
Del Vecchio et al.8 PCR products underwent electrophore-
sis in a 1.5% agarose gel (Type 1-A, Sigma Chemical Co., 
St. Louis, MO), were stained in 5 µg/mL of ethidium bro-
mide, and were visualized using the Gel Doc 1000 system 
and Molecular Analyst software (Bio-Rad Laboratories, 
Hercules, CA). Banding patterns were compared using 
the weighted pair group method with average linkages.9 
A 95% relatedness cutoff was used to deﬁne homologous 
groups. MRSA isolates were later analyzed for the SCC-
mec cassette and Panton–Valentine leukocidin using previ-
ously described techniques.10,11
Study
After approval was obtained from the institution-
al review board of the hospital, a case–control study 
was initiated in September 2001 and ended in January 
2002. A case-patient was defined as an infant who was 
in the NICU during January 1, 2001, through January 
31, 2002, who had a culture positive for MRSA. Case-
patients were further divided as MRSA colonized or in-
fected. Prior to October 14, 2001, control-patients were 
selected randomly from infants who were culture nega-
tive for MRSA and stayed in the NICU during the same 
period as a case-patient. After October 14, 2001, con-
trol-patients were randomly selected from infants with 
negative MRSA surveillance screening cultures. Data 
were collected for 12 cases of MRSA infection, 6 cases 
of MRSA colonization, and 68 control-patients in an ef-
fort to identify risk factors for and potential sources of 
the outbreak. Information was entered into an Access 
database (Microsoft Corp., Redmond, WA) and analyzed 
using SPSS software (version 10.0; SPSS, Inc., Chicago, 
IL). Odds ratios (ORs) for risk factors were generated 
using the chi-square test, and continuous variables were 
compared using the two-tailed t test. Differences were 
considered significant at a P value of .05 or less. 
RESULTS
Sporadic cases (0 to 2 per month) of MRSA infection 
occurred in the NICU during 2001 prior to the outbreak 
(Fig. 1). Six cases of MRSA infection were reported in 
the NICU from January to August 2001, representing an 
attack rate of 5.3%. A cluster of 3 cases of MRSA infection 
in late September 2001 and 3 other cases of MRSA infec-
tion in early October 2001 alerted the staff in the NICU, 
given an increased attack rate of 21.2% (Fig. 1). The num-
ber of MRSA infections per 1,000 patient-days was found 
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to be significantly higher for 2001 compared with 2000 
(3.97 vs 0.46, respectively; relative risk = 8.59; 95% con-
fidence interval [CI95], 1.99 to 37.00; P = .0005). 
An active surveillance system to detect unsuspected 
MRSA colonization was instituted on October 14, 2001, 
and continued until January 31, 2002. A total of 28 infants 
were screened; 6 (21.4%) were found to be colonized with 
MRSA, of whom 4 were identiﬁed in October 2001 and 2 
in November 2001. All had positive cultures from both the 
umbilicus and the rectum. Of 110 HCWs screened by nasal 
swabs, 6 (5.5%) were colonized with MRSA. They included 
1 ultrasound technician, 1 respiratory therapist, and 4 reg-
istered nurses. Although active surveillance was continued 
through January 2002, the last case of MRSA colonization 
among infants was identiﬁed on November 17, 2001. Follow-
ing active surveillance, focused surveillance was continued 
for MRSA infections and all other infections in the NICU, 
and no cases of MRSA infection were identiﬁed during 2½ 
years of follow-up (Fig. 1). 
Of the 18 case-patients described, 12 were infected 
and 6 were colonized with MRSA. Among the colonized in-
fants, there were 4 females and 2 males, all of whom were 
white. There were an equal number of males and females in 
the infected group, of whom 84% were white and 16% were 
African American. Most of the control-patients were white 
(94%) and male (63%). All 12 patients infected with MRSA 
were identiﬁed prior to the initiation of active surveillance 
on October 14, 2001. All 6 colonized patients were identiﬁed 
by active surveillance, and none developed a subsequent 
MRSA infection during their stay in the NICU. Five (42%) 
of the 12 infected patients were infected at more than one 
site. The sites of isolation of MRSA from infected individu-
als were distributed as follows: respiratory secretions, 8 of 
12 (66%); skin and soft tissue, 5 of 12 (42%); eye infection, 3 
of 12 (25%); and blood, 1 of 12 (8%).
Tables 1 and 2 list the signiﬁcant risk factors for 
MRSA infection and colonization, respectively. There was 
an increased risk for MRSA infection among infants who 
were products of multiple gestation (OR, 5.36; CI95, 1.37 to 
20.96), infants with a low mean birth weight (1,347 vs 2,445 
g; P < .001), and infants with a younger gestational age (28.5 
vs 34.4 wk; P = .0002). Similar risk factors were present for 
MRSA colonization. Gavage feeding (OR, 10.33; CI95, 1.28 
to 83.37) and endotracheal intubation (OR, 5.97; CI95, 1.22 
to 29.31) were associated with an increased risk of MRSA 
infection but not colonization.
Maternal antibiotic therapy during pregnancy did 
not increase the rate of subsequent MRSA colonization 
or infection in newborns. Clinical outcomes were gener-
ally favorable. Only one death occurred among patients 
infected with MRSA, although the death was not directly 
related to MRSA. However, infants infected with MRSA 
had a significantly longer stay in the NICU than did in-
fants without MRSA infection (mean, 52 vs 21 days; P = 
.003). 
All MRSA isolates from infants and HCWs identiﬁed 
from September 2001 through January 2002 were analyzed 
by repetitive sequence–based PCR to determine their relat-
edness. Fourteen of these 18 isolates were homologous at 
the 95% level, indicating a difference of 1 band or less. Four 
of the 18 isolates had 90% homology to the remaining iso-
lates and were believed to be subgroups of the same strain 
(Fig. 2). All 18 MRSA isolates had the type II SCCmec cas-
sette and were negative for Panton–Valentine leukocidin, 
features that are characteristic of hospital-acquired MRSA 
strains.
DISCUSSION
This MRSA strain had been present in the NICU 
since at least January 2001 and went unrecognized un-
til a cluster of cases occurred in September 2001. We 
believe it is crucial to be more aggressive even with a 
small number of cases of MRSA in NICUs and to initiate 
appropriate investigations and interventions to prevent 
nosocomial transmission. A major intervention to deal 
with this MRSA outbreak included direct observations 
of the application of infection control measures, includ-
ing adherence with contact isolation and hand hygiene, 
with subsequent feedback to improve compliance. 
Moreover, active surveillance identified additional in-
fants who were colonized with MRSA so that they could 
also be isolated.
The overall clinical outcome was generally favorable 
in our patients with MRSA. The 6 infants detected with 
MRSA colonization after institution of active surveillance 
did not develop subsequent infections. Of the 12 others who 
were infected, the rate of severe infections was relatively 
low, with 1 episode of bacteremia and 3 cases of conjuncti-
vitis. No MRSA-related deaths were reported in our study. 
Other investigators have shown worse outcomes with 
higher rates of invasive disease and severe infections and 
MRSA-related deaths.4,12,13 
On comparison of case-patients with their corre-
FIGURE 1. Epidemiologic curve showing the monthly number of infants 
identiﬁed with methicillin-resistant Staphylococcus aureus (MRSA) infec-
tion or colonization in the neonatal intensive care unit from January 2001 
through June 2002 and the period of active surveillance. Data on MRSA 
colonization are shown only for the period of active surveillance.
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sponding control-patients, infants with MRSA infection had 
a signiﬁcantly increased length of stay, which suggests in-
creased cost. This reinforces previous reports that earlier 
and successful eradication of outbreaks is cost-effective.5,6 
However, in this study, the length of stay was measured 
from the time of admission to the time of discharge from 
the NICU and was not adjusted for birth weight, gesta-
tional age at birth, or severity of illness; therefore, it may 
not be a true reﬂection of the role of MRSA in prolonging 
hospital stay.
This study conﬁrmed low birth weight and young 
gestational age to be signiﬁcant risk factors for colonization 
and infection with MRSA. Infants in this NICU who were 
the product of multiple gestation also had a higher rate of 
MRSA colonization and infection. This ﬁnding has not been 
consistently described as an independent risk factor in the 
literature and may be difﬁcult to interpret because these 
infants often have low birth weights and are born prema-
turely; moreover, twins in this NICU sometimes shared the 
same bed, which might have increased the risk of MRSA 
transmission among them. 
Additional risk factors for infection with MRSA in 
this NICU included gavage feeding and endotracheal in-
tubation. All 12 patients with MRSA infection received ga-
vage feeding and although a statistically signiﬁcant ﬁnd-
ing, this may be only a marker of severity of illness or an 
opportunity for cross-contamination. This study did not 
speciﬁcally address the possibility of intrinsic contamina-
tion of the gavage feeding tubes with MRSA as a possible 
route of transmission, although contamination at the level 
of the manufacturer seems unlikely. Contamination of the 
feeding tubes and extrinsic contamination of the feeds may 
be possible explanations for this ﬁnding because gavage 
feeding requires increased contact between the HCW and 
the patient and thus provides a greater opportunity for 
transmission of MRSA. Also, it is unclear whether endo-
tracheal intubation is an independent risk factor for MRSA 
or an indication of a severe underlying illness that actually 
TABLE 1
RISK FACTORS FOR AND OUTCOMES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION
No. (%) of MRSA- 
Positive Patients
No. (%) of MRSA- 
Negative Patients P* OR (CI95)
Multiple gestation
Yes 5 (42) 8 (12) 5.36 (1.37–20.96)
No 7 (58) 60 (88)
Gavage feeding†
Yes 12 (100) 38 (56) 10.33 (1.28–83.37)
No 0 (0) 30 (44)
Intubation
Yes 10 (83) 31 (46) 5.97 (1.22–29.31)
No 2 (17) 37 (54)
Mean gestational age at birth, wk 28.51 34.41 .0002
Mean birth weight, g 1,347 2,445 < .001
Mean length of stay, d 51.83 21.46 .003
MRSA = methicillin-resistant S. aureus; OR = odds ratio; CI95 = 95% conﬁdence interval. 
*Signiﬁcant at an alpha level of .05. 
†Because all 18 patients with MRSA received gavage feedings, the OR was calculated by adding 1 to each cell.
TABLE 2
RISK FACTORS FOR AND OUTCOMES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS COLONIZATION
No. (%) of MRSA- 
Positive Patients
No. (%) of MRSA-
Negative Patients P* OR (CI95)
Multiple gestation
Yes 5 (83) 8 (12) 37.5 (3.9–363.1)
No 1 (17) 60 (88)
Mean gestational age at birth, wk 29.83 34.41 .0002
Mean birth weight, g 1,522 2,445 < .001
MRSA = methicillin-resistant S. aureus; OR = odds ratio; CI95 = 95% conﬁdence interval. 
*Signiﬁcant at an alpha level of .05.
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predisposes to MRSA infection. Certain body sites (eg, 
respiratory tract secretions and the oropharynx), when 
colonized by MRSA, are particularly resistant to eradica-
tion efforts and may explain the increased risk for invasive 
infections with MRSA in intubated patients.14
Decolonization of the HCWs involved the use of 
intranasal mupirocin in addition to two systemic antibi-
otics and antibacterial showers. This particular regimen 
was selected by the local physicians at the study hospital 
and was not recommended by the authors of this article. 
In previously described outbreaks, the use of intranasal 
mupirocin or fuscidic acid as single agents or in combi-
nation with hexachlorophene showers or the combina-
tion of trimethoprim–sulfamethoxazole and rifampin was 
enough to decolonize NICU HCWs.2,4,12 The adoption of 
an aggressive approach may be warranted in an effort to 
achieve earlier control of the spread of MRSA in a NICU. 
However, although the antibiotics were used for a short 
time and the likelihood of complications and emergence 
of resistance was low, this regimen should not be recom-
mended for routine use in similar situations.
MRSA strains were compared using the repetitive 
sequence PCR technique. This technique is performed 
more easily and more quickly than pulsed-ﬁeld gel elec-
trophoresis and would therefore be an advantage in out-
break situations. Repetitive sequence PCR using RW3A 
primer was shown to be at least as discriminatory as and 
comparable to pulsed-ﬁeld gel electrophoresis for epi-
demiologic separation of MRSA strains in two different 
studies.15,16 In addition, in the recent article by Healy et 
al., repetitive sequence PCR was used to type isolates 
of MRSA recovered from infants in a NICU.17 This tech-
nique is probably going to be used more widely in the 
future.
This study did not intend to evaluate the effective-
ness of each of the infection control methods. Assessing 
the efﬁcacy of individual measures during an outbreak 
is a difﬁcult task because hospitals implement multiple 
control measures simultaneously in an effort to quickly 
contain the outbreak. Another limitation of the study was 
difﬁculty identifying the initial source of MRSA and the ex-
act methods of MRSA transmission, although the MRSA 
strains from the infants and the HCWs were identical. 
Because of the structure of the NICU, where the ratio of 
HCWs to infants was not 1:1, and because of the imper-
fect documentation of every activity involving the infants, 
it is difﬁcult to implicate a particular HCW in the spread of 
MRSA in the NICU. 
Successful and durable eradication of a MRSA 
outbreak was achieved in this NICU after implementing 
aggressive infection control measures. These measures 
included direct observation and identiﬁcation of deﬁcien-
cies in the application of infection control procedures, 
education of NICU HCWs about the importance of hand 
hygiene and proper contact isolation, active surveillance 
to identify colonized infants and HCWs, establishment 
of contact isolation and cohorting for infected and col-
onized patients, and use of decolonization regimens to 
treat colonized infants and HCWs. We believe that educa-
tion of HCWs by infection control nurses who ensured 
compliance with infection control measures played a 
major role in halting the epidemic and achieving long-
term results. Continued education of HCWs is needed 
to ensure the application of proper contact isolation for 
patients infected or colonized with MRSA, especially in 
outbreak situations. Early action, even for a few patients 
with MRSA, is essential to prevent acquisition and trans-
mission of MRSA in NICUs.
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